Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Zahn

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Journal of Drugs in Dermatology : JDD|April 7, 2022
Offering an Off-Label Therapeutic Algorithm for Lichen PlanusDillon Nussbaum, Jessica Kalen, Joseph Zahn, et al.
Journal of Drugs in Dermatology : JDD|March 8, 2021
Successful Treatment of Lichen Amyloidosis Using a Fixed Combination of Halobetasol-Propionate and Tazarotene LotionEzra Shoen, Angela Hou, Joseph Zahn, et al.
Advances in Therapy|May 8, 2025
Dupilumab Efficacy in Children with Atopic Dermatitis with Different Phenotypes and Endotypes: A Case SeriesAna B Rossi, Adriana M Mello, Joseph Zahn
Journal of Drugs in Dermatology : JDD|October 7, 2020
Is TNF-α Inhibitor-Induced Psoriasiform Dermatitis Always Psoriasiform?Chapman Wei, Emily C Murphy, Joseph Zahn, et al.
The Journal of Allergy and Clinical Immunology|August 23, 2024
Dupilumab reduces inflammatory biomarkers in pediatric patients with moderate-to-severe atopic dermatitisLisa A Beck, Antonella Muraro, Mark Boguniewicz, et al.
The American Journal of Dermatopathology|July 4, 2019
A Case of Adjacent, Clonally Distinct Borderline Melanocytic Tumors on the ArmAndrew Schuler, Mallory Smith, Joseph Zahn, et al.
The Journal of Dermatological Treatment|February 17, 2026
Prurigo Nodularis paTient Reported burdEn of sicKness in Europe (PN TREK Europe): a cross-sectional survey of patient-reported burden of disease in patients with PN from four countries in EuropeSonja Ständer, Min Yang, Bruno Martins, et al.
Dermatology and Therapy|April 1, 2026
Dupilumab Improves Prurigo Activity and Severity in Patients with Prurigo Nodularis: A Post Hoc Analysis of Pooled Results from the PRIME and PRIME2 TrialsSonja Stander, Claudia Zeidler, Jerome Msihid, et al.
Journal of Cutaneous Pathology|April 24, 2019
Altered Rb, p16, and p53 expression is specific for porocarcinoma relative to poromaJoseph Zahn, May P Chan, Grace Wang, et al.
Experimental Dermatology|September 20, 2023
Nano-encapsulated anandamide reduces inflammatory cytokines in vitro and lesion severity in a murine model of cutaneous lupus erythematosusErika T McCormick, Andrew Draganski, Samantha Chalmers, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Journal of Drugs in Dermatology : JDD|April 7, 2022
Offering an Off-Label Therapeutic Algorithm for Lichen PlanusDillon Nussbaum, Jessica Kalen, Joseph Zahn, et al.
Journal of Drugs in Dermatology : JDD|March 8, 2021
Successful Treatment of Lichen Amyloidosis Using a Fixed Combination of Halobetasol-Propionate and Tazarotene LotionEzra Shoen, Angela Hou, Joseph Zahn, et al.
Advances in Therapy|May 8, 2025
Dupilumab Efficacy in Children with Atopic Dermatitis with Different Phenotypes and Endotypes: A Case SeriesAna B Rossi, Adriana M Mello, Joseph Zahn
Journal of Drugs in Dermatology : JDD|October 7, 2020
Is TNF-α Inhibitor-Induced Psoriasiform Dermatitis Always Psoriasiform?Chapman Wei, Emily C Murphy, Joseph Zahn, et al.
The Journal of Allergy and Clinical Immunology|August 23, 2024
Dupilumab reduces inflammatory biomarkers in pediatric patients with moderate-to-severe atopic dermatitisLisa A Beck, Antonella Muraro, Mark Boguniewicz, et al.
The American Journal of Dermatopathology|July 4, 2019
A Case of Adjacent, Clonally Distinct Borderline Melanocytic Tumors on the ArmAndrew Schuler, Mallory Smith, Joseph Zahn, et al.
The Journal of Dermatological Treatment|February 17, 2026
Prurigo Nodularis paTient Reported burdEn of sicKness in Europe (PN TREK Europe): a cross-sectional survey of patient-reported burden of disease in patients with PN from four countries in EuropeSonja Ständer, Min Yang, Bruno Martins, et al.
Dermatology and Therapy|April 1, 2026
Dupilumab Improves Prurigo Activity and Severity in Patients with Prurigo Nodularis: A Post Hoc Analysis of Pooled Results from the PRIME and PRIME2 TrialsSonja Stander, Claudia Zeidler, Jerome Msihid, et al.
Journal of Cutaneous Pathology|April 24, 2019
Altered Rb, p16, and p53 expression is specific for porocarcinoma relative to poromaJoseph Zahn, May P Chan, Grace Wang, et al.
Experimental Dermatology|September 20, 2023
Nano-encapsulated anandamide reduces inflammatory cytokines in vitro and lesion severity in a murine model of cutaneous lupus erythematosusErika T McCormick, Andrew Draganski, Samantha Chalmers, et al.
Pageof 3